- Long-term clinical and real-world experience with Crohn’s disease treated with anti-tumor necrosis factor-α antibodies
-
Otake H, Matsumoto S, Mashima H
- KMID: 2535820
- Intest Res.
- 2022 Oct;20(4):464-474.
- doi: 10.5217/ir.2021.00139
Background/Aims: Although anti-tumor necrosis factor (TNF)-α agents are important therapeutic drugs for Crohn’s disease (CD), data regarding their long-term sustained effects are limited. Herein, we evaluated the long-term loss of... -
- CITED
-
- Close
- SHARE
-
- Close
